These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10576617)

  • 1. Effects of the phosphodiesterase inhibitor rolipram on streptococcal cell wall-induced arthritis in rats.
    Laemont KD; Schaefer CJ; Juneau PL; Schrier DJ
    Int J Immunopharmacol; 1999 Nov; 21(11):711-25. PubMed ID: 10576617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation.
    Sekut L; Yarnall D; Stimpson SA; Noel LS; Bateman-Fite R; Clark RL; Brackeen MF; Menius JA; Connolly KM
    Clin Exp Immunol; 1995 Apr; 100(1):126-32. PubMed ID: 7697910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis.
    Francischi JN; Yokoro CM; Poole S; Tafuri WL; Cunha FQ; Teixeira MM
    Eur J Pharmacol; 2000 Jul; 399(2-3):243-9. PubMed ID: 10884526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoprenaline induction of cAMP-phosphodiesterase in guinea-pig macrophages occurs in the presence, but not in the absence, of the phosphodiesterase type IV inhibitor rolipram.
    Kochetkova M; Burns FM; Souness JE
    Biochem Pharmacol; 1995 Dec; 50(12):2033-8. PubMed ID: 8849330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between the antidepressant-like behavioral effects of beta adrenergic agonists and the cyclic AMP PDE inhibitor rolipram in rats.
    Zhang HT; Huang Y; Mishler K; Roerig SC; O'Donnell JM
    Psychopharmacology (Berl); 2005 Oct; 182(1):104-15. PubMed ID: 16010541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of interleukin-10 and modulators of cyclic AMP formation on endotoxin-induced inflammation in rat lung.
    Escofier N; Boichot E; Germain N; Silva PM; Martins MA; Lagente V
    Fundam Clin Pharmacol; 1999; 13(1):96-101. PubMed ID: 10027094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of tumour necrosis factor production by adrenal hormones in vivo: insights into the antiinflammatory activity of rolipram.
    Pettipher ER; Labasi JM; Salter ED; Stam EJ; Cheng JB; Griffiths RJ
    Br J Pharmacol; 1996 Apr; 117(7):1530-4. PubMed ID: 8730750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of cAMP modulation upon the adhesion and respiratory burst activity of immune complex-stimulated equine neutrophils.
    Chilcoat CD; Rowlingson KA; Jones SL
    Vet Immunol Immunopathol; 2002 Sep; 88(1-2):65-77. PubMed ID: 12088646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacodynamic action of the cyclic AMP phosphodiesterase inhibitor rolipram on prolactin producing rat pituitary adenoma (GH4C1) cells.
    Gordeladze JO
    Biosci Rep; 1990 Aug; 10(4):375-88. PubMed ID: 2174276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
    Seldon PM; Barnes PJ; Meja K; Giembycz MA
    Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic and topical drug administration in the pig ureter: effect of phosphodiesterase inhibitors alpha1, beta and beta2-adrenergic receptor agonists and antagonists on the frequency and amplitude of ureteral contractions.
    Danuser H; Weiss R; Abel D; Walter B; Scholtysik G; Mettler D; Studer UE
    J Urol; 2001 Aug; 166(2):714-20. PubMed ID: 11458123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibitory effect of rolipram on TNF-alpha production in mouse blood ex vivo is dependent upon the release of corticosterone and adrenaline.
    Pettipher ER; Eskra JD; Labasi JM
    Cytokine; 1997 Aug; 9(8):582-6. PubMed ID: 9245486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rolipram, a specific type IV phosphodiesterase inhibitor, ameliorates aspirin-induced gastric mucosal injury in rats.
    Odashima M; Otaka M; Jin M; Komatsu K; Konishi N; Wada I; Horikawa Y; Matsuhashi T; Ohba R; Oyake J; Hatakeyama N; Watanabe S
    Dig Dis Sci; 2005 Jun; 50(6):1097-102. PubMed ID: 15986861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors.
    Wollin L; Bundschuh DS; Wohlsen A; Marx D; Beume R
    Pulm Pharmacol Ther; 2006; 19(5):343-52. PubMed ID: 16257550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor.
    Prabhakar U; Lipshutz D; Bartus JO; Slivjak MJ; Smith EF; Lee JC; Esser KM
    Int J Immunopharmacol; 1994 Oct; 16(10):805-16. PubMed ID: 7843852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenergic receptor regulation of macrophage-derived tumor necrosis factor-alpha production from rats with experimental arthritis.
    Chou RC; Stinson MW; Noble BK; Spengler RN
    J Neuroimmunol; 1996 Jun; 67(1):7-16. PubMed ID: 8707933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of acute lung injury in mice by an inhibitor of phosphodiesterase type 4.
    Miotla JM; Teixeira MM; Hellewell PG
    Am J Respir Cell Mol Biol; 1998 Mar; 18(3):411-20. PubMed ID: 9490659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation.
    Eckly-Michel A; Martin V; Lugnier C
    Br J Pharmacol; 1997 Sep; 122(1):158-64. PubMed ID: 9298542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of a Novel PDE4 inhibitor ZL-n-91 on lipopolysaccharide-induced acute lung injury.
    Tang HF; Lu JJ; Tang JF; Zheng X; Liang YQ; Wang XF; Wang YJ; Mao LG; Chen JQ
    Int Immunopharmacol; 2010 Apr; 10(4):406-11. PubMed ID: 20074667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram.
    Sullivan GW; Linden J; Buster BL; Scheld WM
    J Infect Dis; 1999 Nov; 180(5):1550-60. PubMed ID: 10515815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.